SCHEMBL159644

SCHEMBL159644

CCCCC/C=C/C(C)=O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 4/20 0.55
FASN P49327 1/20 0.53
PPARG P37231 5/20 0.53
PPARA Q07869 5/20 0.53
TERT O14746 3/20 0.52
PPARD Q03181 3/20 0.52
CYP1A2 P05177 2/20 0.52
MAPT P10636 2/20 0.52
CYP2C19 P33261 2/20 0.52
BLM P54132 2/20 0.52
HSD17B10 Q99714 2/20 0.52
FABP4 P15090 2/20 0.52
FAAH O00519 2/20 0.52
KMT2A Q03164 2/20 0.52
GMNN O75496 1/20 0.52
USP2 O75604 1/20 0.52
LMNA P02545 1/20 0.52
POLB P06746 1/20 0.52
CYP2C9 P11712 1/20 0.52
ALOX15 P16050 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL159645 1.00 PTPN1 (0.55) PTPN1FASNPPARGPPARATERT
SCHEMBL28956254 1.00 PTPN1 (0.55) PTPN1FASNPPARGPPARATERT
SCHEMBL8441219 0.98 PTPN1 (0.58) PTPN1FASNPPARGPPARATERT
SCHEMBL8443714 0.98 PTPN1 (0.58) PTPN1FASNPPARGPPARATERT
SCHEMBL8440536 0.98 PTPN1 (0.58) PTPN1FASNPPARGPPARATERT
SCHEMBL1129945 0.98 PTPN1 (0.58) PTPN1FASNPPARGPPARATERT
SCHEMBL8444866 0.98 PTPN1 (0.58) PTPN1FASNPPARGPPARATERT
SCHEMBL1129290 0.98 PTPN1 (0.58) PTPN1FASNPPARGPPARATERT
SCHEMBL8441217 0.98 PTPN1 (0.58) PTPN1FASNPPARGPPARATERT
SCHEMBL6903523 0.98 PTPN1 (0.58) PTPN1FASNPPARGPPARATERT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 575 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250282743-A1 METHODS OF SYNTHESIZING CANNABIDIOL, DERIVATIVES THEREOF, AND OTHER PHYTOCANNABINOIDS CITRACHEM CORP. 2025-09-11 US claimed
US-12295388-B2 Methods of modulating gastrointestinal metabolites DSM IP ASSETS B.V. (NL) 2025-05-13 US claimed
CN-119924491-A Flavoring composition with balanced taste characteristics 西姆莱斯有限公司 2025-05-06 CN claimed
US-20250066343-A1 NOVEL CANNABICHROMENIC ACID DERIVATIVE, PREPARATION METHOD THEREFOR, AND COMPOSITION COMPRISING SAME FOR IMPROVING COGNITIVE FUNCTION K-Medichem Co., Ltd. (KR) 2025-02-27 US claimed
US-20240426829-A1 COMPOSITIONS AND METHODS FOR THE DETECTION OF BRAIN INJURY CHILDRENS HOSPITAL PHILADELPHIA (US) 2024-12-26 US claimed
CN-118755740-A Vanilla DmGA ox3 gene and application thereof 陕西省西安植物园(陕西省植物研究所) 2024-10-11 CN claimed
EP-4434975-A1 NOVEL CANNABICHROMENIC ACID DERIVATIVE, PREPARATION METHOD THEREFOR, AND COMPOSITION COMPRISING SAME FOR IMPROVING COGNITIVE FUNCTION K-Medichem Co., Ltd. (KR) 2024-09-25 EP claimed
US-20240306688-A1 METHOD OF MITIGATING OFF-ODORS GIVAUDAN SA (CH) 2024-09-19 US claimed
US-20240298681-A1 METHODS AND COMPOSITIONS FOR AFFECTING THE FLAVOR AND AROMA PROFILE OF CONSUMABLES IMPOSSIBLE FOODS INC. 2024-09-12 US claimed
CN-114890894-B Synthesis method of 2, 4-dihydroxy-6-amyl methyl benzoate 西安岳达生物科技股份有限公司 2024-08-20 CN claimed
WO-2002058464-A2 USE OF α,β UNSATURATED ALIPHATIC ALDEHYDES AND KETONES TO INHIBIT POTATO TUBER SPROUTING WASHINGTON STATE UNIVERSITY RESEARCH FOUNDATION (US) 2002-08-01 WO claimed
EP-1223157-A1 Use of 4-substituted 2-butanones to prepare nabumetone HOECHST CELANESE CORPORATION (US) 2002-07-17 EP claimed
EP-1223156-A1 Use of 4-substituted 2-butanones to prepare nabumetone HOECHST CELANESE CORPORATION (US) 2002-07-17 EP claimed
WO-2002043675-A2 IMMOBILISATION OF ACTIVE AGENTS ON FIBRES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2002-06-06 WO claimed
US-20020037479-A1 Photoresist strippers containing reducing agents to reduce metal corrosion MALLINCKRODT BAKER, INC. 2002-03-28 US claimed
EP-0892775-A2 USE OF 4-SUBSTITUTED 2-BUTANONES TO PREPARE NABUMETONE HOECHST CELANESE CORPORATION (US) 1999-01-27 EP claimed
EP-0647884-B1 Photoresist strippers containing reducing agents to reduce metal corrosion MALLINCKRODT BAKER INC (US) 1998-04-08 EP claimed
US-5600009-A Use of 4-substituted 2-butanones to prepare nabumetone HOECHST CELANESE CORPORATION (US) 1997-02-04 US claimed
WO-1996040608-A2 USE OF 4-SUBSTITUTED 2-BUTANONES TO PREPARE NABUMETONE HOECHST CELANESE CORPORATION (US) 1996-12-19 WO claimed
EP-0647884-A1 Photoresist strippers containing reducing agents to reduce metal corrosion MALLINCKRODT BAKER, Inc. (US) 1995-04-12 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250066343-A1 NOVEL CANNABICHROMENIC ACID DERIVATIVE, PREPARATION METHOD THEREFOR, AND COMPOSITION COMPRISING SAME FOR IMPROVING COGNITIVE FUNCTION BCHE, NOTUM, ACHE PTPN1 4550/4885FASN 477/4885PPARG 1266/4885
US-20250282743-A1 METHODS OF SYNTHESIZING CANNABIDIOL, DERIVATIVES THEREOF, AND OTHER PHYTOCANNABINOIDS CNR2, CNR1, CYP8B1 PTPN1 4478/4885FASN 98/4885PPARG 297/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.